Literature DB >> 9201643

Epidemiologic advances in chronic fatigue syndrome.

P H Levine1.   

Abstract

Epidemiologic studies of chronic fatigue syndrome (CFS) have been hampered by the absence of a specific diagnostic test, but with increasing interest in this disorder there has been a greater understanding of the risk factors, illness patterns, and other aspects of this multisystem disorder. Working case definitions have been developed for research purposes but they have continued to change over time and have not always been utilized precisely by various investigators. This has been a major factor in the widely varying estimates of prevalence rates, but two different studies using the same working definition and including a medical work-up have estimated the prevalence to be approximately 200/100,000. Clusters of CFS cases, which appear to be related to earlier reports of "epidemic neuromyasthenia", have attracted considerable attention and appear to be well documented, although investigated with varying methodology and often with dissimilar case definitions. Risk factors for cases occurring in clusters and sporadically appear to be similar, the most consistent ones being female gender and the co-existence of some form of stress, either physical or psychological. The prognosis of CFS is difficult to predict, although cases occurring as part of clusters appear to have a better prognosis as a group than sporadic cases, and those with an acute onset have a better prognosis than those with gradual onset. It is highly unlikely that there is a single agent, infectious or noninfectious, that is responsible for more than a small proportion of CFS cases and, at the present time, the risk factors for developing CFS appear to lie more prominently in the host rather than the environment.

Entities:  

Mesh:

Year:  1997        PMID: 9201643     DOI: 10.1016/s0022-3956(96)00058-1

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  9 in total

Review 1.  Chronic fatigue syndrome: the need for subtypes.

Authors:  Leonard A Jason; Karina Corradi; Susan Torres-Harding; Renee R Taylor; Caroline King
Journal:  Neuropsychol Rev       Date:  2005-03       Impact factor: 7.444

2.  Subtyping Patients with Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS) By Course of Illness.

Authors:  Jamie Stoothoff; Kristen Gleason; Stephanie McManimen; Taylor Thorpe; Leonard A Jason
Journal:  J Biosens Biomark Diagn       Date:  2017-06-26

3.  The prevalence of self-reported chronic fatigue in a U.S. twin registry.

Authors:  Helena Furberg; Megan Olarte; Niloo Afari; Jack Goldberg; Dedra Buchwald; Patrick F Sullivan
Journal:  J Psychosom Res       Date:  2005-11       Impact factor: 3.006

Review 4.  Chronic fatigue syndrome: an update.

Authors:  R J Shephard
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

5.  The prognosis after multidisciplinary treatment for patients with postinfectious chronic fatigue syndrome and noninfectious chronic fatigue syndrome.

Authors:  Akinori Masuda; Takashi Nakayama; Takao Yamanaka; Yasuyuki Koga; Chuwa Tei
Journal:  J Behav Med       Date:  2002-10

6.  Childhood predictors of self reported chronic fatigue syndrome/myalgic encephalomyelitis in adults: national birth cohort study.

Authors:  Russell Viner; Matthew Hotopf
Journal:  BMJ       Date:  2004-10-06

7.  EBV Chronic Infections.

Authors:  Pizzigallo Eligio; Racciatti Delia; Gorgoretti Valeria
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-08-10       Impact factor: 2.576

8.  A Disease Register for ME/CFS: Report of a Pilot Study.

Authors:  Derek Pheby; Eliana Lacerda; Luis Nacul; Maria de Lourdes Drachler; Peter Campion; Amanda Howe; Fiona Poland; Monica Curran; Valerie Featherstone; Shagufta Fayyaz; Dikaios Sakellariou; José Carlos de Carvalho Leite
Journal:  BMC Res Notes       Date:  2011-05-09

9.  The Role of Prevention in Reducing the Economic Impact of ME/CFS in Europe: A Report from the Socioeconomics Working Group of the European Network on ME/CFS (EUROMENE).

Authors:  Derek F H Pheby; Diana Araja; Uldis Berkis; Elenka Brenna; John Cullinan; Jean-Dominique de Korwin; Lara Gitto; Dyfrig A Hughes; Rachael M Hunter; Dominic Trepel; Xia Wang-Steverding
Journal:  Medicina (Kaunas)       Date:  2021-04-16       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.